All Stories

  1. Consultation report - gonococcal immunoassays and standards for vaccine development
  2. Virus-neutralizing SIgA may be compromised by bacterial enzymes that cleave human IgA1
  3. Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum
  4. Microencapsulated IL-12 Drives Genital Tract Immune Responses to Intranasal Gonococcal Outer Membrane Vesicle Vaccine and Induces Resistance to Vaginal Infection with Diverse Strains of Neisseria gonorrhoeae
  5. Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
  6. Review of: "A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent Patients"
  7. Immune Responses to Neisseria gonorrhoeae: Challenges and Opportunities With Respect to Pelvic Inflammatory Disease
  8. COVID-19 and mucosal immunity.
  9. Immunity to gonorrhea
  10. Historical Perspectives on Mucosal Vaccines
  11. Immunity to the gonococcus
  12. A review of the current state of developing a vaccine against gonorrhea
  13. A review of immunity in the male and female genital tracts and its role in defense against STI
  14. Editorial summarizing the current status of approaches to vaccination against gonorrhea.
  15. Generating an effective immune response against gonorrhea
  16. Novel approach to developing a vaccine against gonorrhea
  17. Immunity at the internal surfaces of the body
  18. Thinking Globally, Acting Locally: Harnessing the Immune System to Deal with Recalcitrant Pathogens
  19. Mucosal Vaccines
  20. Innate Humoral Defense Factors
  21. Microbial Evasion of IgA Functions
  22. Urogenital Tract and Mammary Gland
  23. Phylogeny and Comparative Physiology of Mucosal Immunoglobulins
  24. Biological Activities of IgA
  25. Overview
  26. Preface to the Fourth Edition
  27. Immunity to Sexually Transmitted Infections
  28. Historical Aspects of Mucosal Immunology
  29. Mucosal Immunity in the Oral Cavity, Upper Respiratory Tract, and Adjacent Areas
  30. Mucosal Immunology
  31. Intestinal Immunoglobulin A: Role in Host Defense
  32. Vaccines against gonorrhea: Current status and future challenges
  33. Identification and Characterization of Intestinal Antigen-Presenting Cells Involved in Uptake and Processing of a Nontoxic Recombinant Chimeric Mucosal Immunogen Based on Cholera Toxin Using Imaging Flow Cytometry
  34. Enhancement of Adaptive Immunity to Neisseria gonorrhoeae by Local Intravaginal Administration of Microencapsulated Interleukin 12
  35. Suppression of host adaptive immune responses by Neisseria gonorrhoeae: role of interleukin 10 and type 1 regulatory T cells
  36. Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-β-dependent mechanisms
  37. Contrasting Roles of IL-22 and IL-17 in Murine Genital Tract Infection by Neisseria gonorrhoeae
  38. Structure and function relationships in IgA
  39. Diversion of the Immune Response to Neisseria gonorrhoeae from Th17 to Th1/Th2 by Treatment with Anti-Transforming Growth Factor β Antibody Generates Immunological Memory and Protective Immunity
  40. Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins
  41. New Concepts in Immunity to Neisseria Gonorrhoeae: Innate Responses and Suppression of Adaptive Immunity Favor the Pathogen, Not the Host
  42. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection
  43. Mucosal Decisions: Tolerance and Responsiveness at Mucosal Surfaces
  44. Tolerance and Protection against Infection in the Genital Tract
  45. In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli
  46. Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces
  47. Gonorrhea
  48. Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae
  49. Molecular heterogeneity of human IgA antibodies during an immune response
  50. Tissue distribution of lymphocytes and plasma cells and the role of the gut
  51. Terminology: nomenclature of mucosa-associated lymphoid tissue
  52. Perspectives on Mucosal Vaccines: Is Mucosal Tolerance a Barrier?
  53. Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice
  54. The A Subunit of Type IIb Enterotoxin (LT-IIb) Suppresses the Proinflammatory Potential of the B Subunit and Its Ability to Recruit and Interact with TLR2
  55. Analysis of the cellular immune response induced by Bacillus thuringiensis Cry1A toxins in mice: Effect of the hydrophobic motif from diphtheria toxin
  56. In Vitro Induction of Immunoglobulin A (IgA)- and IgM-Secreting Plasma Blasts by Cholera Toxin Depends on T-Cell Help and Is Mediated by CD154 Up-Regulation and Inhibition of Gamma Interferon Synthesis
  57. Biological Functions of IgA
  58. Mutants of Type II Heat-Labile Enterotoxin LT-IIa with Altered Ganglioside-Binding Activities and Diminished Toxicity Are Potent Mucosal Adjuvants
  59. Immunomodulation with Enterotoxins for the Generation of Secretory Immunity or Tolerance: Applications for Oral Infections
  60. Induction and recall of immune memory by mucosal immunization with a non-toxic recombinant enterotoxin-based chimeric protein
  61. Intranasal Administration of Recombinant Neisseria gonorrhoeae Transferrin Binding Proteins A and B Conjugated to the Cholera Toxin B Subunit Induces Systemic and Vaginal Antibodies in Mice
  62. Differential Binding of Escherichia coli Enterotoxins LT-IIa and LT-IIb and of Cholera Toxin Elicits Differences in Apoptosis, Proliferation, and Activation of Lymphoid Cells
  63. Immunologic Uniqueness of the Genital Tract: Challenge for Vaccine Development
  64. Mucosal Adjuvant Properties of Mutant LT-IIa and LT-IIb Enterotoxins That Exhibit Altered Ganglioside-Binding Activities
  65. Toll-Like Receptor 2 Mediates Cellular Activation by the B Subunits of Type II Heat-Labile Enterotoxins
  66. Biological Activities of IgA
  67. Microbial Evasion of IgA Functions
  68. Phylogeny and Comparative Physiology of IgA
  69. Innate Humoral Defense Factors
  70. Mucosal Immunology of Sexually Transmitted Diseases
  71. The Type II Heat-Labile Enterotoxins LT-IIa and LT-IIb and Their Respective B Pentamers Differentially Induce and Regulate Cytokine Production in Human Monocytic Cells
  72. The State of the Science of Immunization against Dental Caries
  73. Mucosal Immunity
  74. Interactions of Oral Pathogens With Toll-Like Receptors: Possible Role in Atherosclerosis
  75. Humoral immune responses to microbial infections in the genital tract
  76. Immunization for Protection of the Reproductive Tract: A Review
  77. Dependence of Bacterial Protein Adhesins on Toll-Like Receptors for Proinflammatory Cytokine Induction
  78. Identification and Characterization of a Nonimmunoglobulin Factor in Human Saliva That Inhibits Streptococcus mutans Glucosyltransferase
  79. Effect of Attenuated Salmonella enterica Serovar Typhimurium Expressing a Streptococcus mutans Antigen on Secondary Responses to the Cloned Protein
  80. Urethral Cytokine and Immune Responses inChlamydia trachomatis-Infected Males
  81. Mechanisms of Immune Tolerance to Food Antigens in Humans
  82. Intestinal Macrophages Lack CD14 and CD89 and Consequently Are Down-Regulated for LPS- and IgA-Mediated Activities
  83. Distinct Cytokine Regulation by Cholera Toxin and Type II Heat-Labile Toxins Involves Differential Regulation of CD40 Ligand on CD4+ T Cells
  84. Long-term persistence and recall of immune responses in aged mice after mucosal immunization
  85. Recombinant Antigen-Enterotoxin A2/B Chimeric Mucosal Immunogens Differentially Enhance Antibody Responses and B7-Dependent Costimulation of CD4+ T Cells
  86. Strategies of immunization against mucosal infections
  87. Generation of Female Genital Tract Antibody Responses by Local or Central (Common) Mucosal Immunization
  88. Induction of mucosal immune responses in the human genital tract
  89. A method for quantification of absolute amounts of nucleic acids by (RT)-PCR and a new mathematical model for data analysis
  90. Induction of mucosal immune responses in the human genital tract
  91. Comparative Analysis of the Mucosal Adjuvanticity of the Type II Heat-Labile Enterotoxins LT-IIa and LT-IIb
  92. Mucosal Immunity in the Genital Tract: Prospects for Vaccines Against Sexually Transmitted Diseases-A Review
  93. Intestinal IgA: novel views on its function in the defence of the largest mucosal surface
  94. Cholera Toxin B Subunit as an Immunomodulator for Mucosal Vaccine Delivery
  95. Immunity to tooth decay
  96. Cytokine and Antibody Responses in Women Infected withNeisseria gonorrhoeae:Effects of Concomitant Infections
  97. Passive and active protection against disorders of the gut
  98. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant
  99. Nasal Lymphoid Tissue (NALT) as a Mucosal Immune Inductive Site
  100. Current options for vaccine delivery systems by mucosal routes
  101. Establishment of aStreptococcus pneumoniaenasopharyngeal colonization model in adult mice
  102. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system
  103. IgA antibody as a non-inflammatory regulator of immunity
  104. Mucosal immunoglobulins and their contribution to defence mechanisms: an overview
  105. Intranasal Immunization of Mice with PspA (Pneumococcal Surface Protein A) Can Prevent Intranasal Carriage, Pulmonary Infection, and Sepsis with Streptococcus pneumoniae
  106. Construction and oral immunogenicity of a Salmonella typhimurium strain expressing a streptococcal adhesin linked to the subunits of cholera toxin
  107. Systemic and Mucosal Protective Immunity to Pneumococcal Surface Protein A
  108. Induction of antibody‐secreting cells and T‐helper and memory cells in murine nasal lymphoid tissue
  109. Advances in Mucosal Immunology.Jiri Mestecky , Michael W. Russell , Susan Jackson , Suzanne M. Michalek , Helena Tlaskalova-Hogenova , Jaroslav Sterzl
  110. Compartmentalization within the Common Mucosal Immune System
  111. Secretory IgA response in oral immunotherapy.
  112. Affinity and Specificity of the Interactions between Streptococcus mutans Antigen I/II and Salivary Components
  113. All Forms of Human IgA Antibodies Bound to Antigen Interfere with Complement (C3) Fixation Induced by IgG or by Antigen Alone
  114. Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B su
  115. Function of Mucosal Immunoglobulins
  116. Serum antibody responses to Streptococcus mutans antigens in humans systemically infected with oral streptococci
  117. Liposomes and Conjugate Vaccines for Antigen Delivery and Induction of Mucosal Immune Responses
  118. Streptococcus Mutans And The Problem of Heart Cross-Reactivity
  119. Induction of human secretory and serum immune responses: molecular properties of IgA antibodies
  120. Anti‐inflammatory activity of human IgA antibodies and their Fabα fragments: inhibition of IgG‐mediated complement activation
  121. Complement-Fixing Properties of Human IgA Antibodies Alternative Pathway Complement Activation by Plastic-Bound, But Not Specific Antigen-Bound, IgA
  122. Interaction between surface protein antigens of Streptococcus mutans and human salivary components
  123. Serum and Salivary IgA1, IgA2, IgG and IgM Antibodies to Bacterial Antigens in Aged, Edentulous, and Normal Adults
  124. Comparative Studies of the Biological Properties of Human IgA Subclasses
  125. Role of hepatocytes in the uptake of IgA and IgA-containing immune complexes in mice
  126. Induction of the Mucosal Immune Response
  127. Striking Elevation of Serum IgA, IgA-Containing Immune Complexes, and IgA Rheumatoid Factor in Clinically Silent Dermatitis Herpetiformis
  128. Analysis of heart-reactive antibodies induced in rabbits by immunization with Streptococcus mutans
  129. IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans.
  130. Detection of Food Antigen-Specific IgA Immune Complexes in Human Sera
  131. The human IgA system: A reassessment
  132. Analysis of the hepatobiliary transport of IgA with monoclonal anti-idiotype and anti-allotype antibodies
  133. Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies
  134. IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli
  135. Secretory IgA1 and IgA2 Responses to Environmental Antigens
  136. Evidence for a Common Mucosal Immune System in Humans
  137. Selective hepatobiliary transport of human polymeric IgA in mice
  138. SELECTIVE HEPATOBILIARY TRANSPORT OF MONOCLONAL IgG, BUT NOT IgM ANTI-IDIOTYPIC ANTIBODIES, BY IgA
  139. FUNCTION AND BIOSYNTHESIS OF POLYMERIC IgA
  140. IgA-MEDIATED HEPATOBILIARY CLEARANCE OF BACTERIAL ANTIGENS
  141. Preferential transport of IgA and IgA-immune complexes to bile compared with other external secretions
  142. Researchers insecure
  143. Role of serum IgA. Hepatobiliary transport of circulating antigen
  144. IMMUNISATION WITH A PURIFIED PROTEIN FROM STREPTOCOCCUS MUTANS AGAINST DENTAL CARIES IN RHESUS MONKEYS
  145. PASSIVE IMMUNISATION WITH SERUM AND IMMUNOGLOBULINS AGAINST DENTAL CARIES IN RHESUS MONKEYS
  146. Characterisation of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c
  147. Diagnostic Significance of Antibodies in Oral Secretions